GGrantIndex
← Leaderboards

Mark L Williams

University Of Texas Hlth Sci Ctr Houston

$11,981,954
Attributed
$11,981,954
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,981,954 · 9

By mechanism

R01$8,230,714 · 4
P50$2,962,748 · 1
R21$698,337 · 2
R03$84,130 · 1
M01$6,025 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Sci Ctr Houston

Same institution · by research overlap

Others in their field

Top investigators on “Behavioral /Social Science Research Tag

Research focus

Behavioral /Social Science Research TagHuman SubjectAfrican AmericanHiv InfectionsCrack CocaineDrug AbuseClinical ResearchCondomsPatient Oriented ResearchSex BehaviorResearch Project GrantsBeliefHuman Therapy EvaluationDesignCommunitiesReadinessResearch PersonnelDisease /Disorder Proneness /RiskAids Education /PreventionProgramsInnovationLongitudinal Human StudyHealth BehaviorComorbidity

Grant awards (28)

Investigator Development Core$587,825
P50 · FY2025 · MD · contact PI
Investigator Development Core$587,826
P50 · FY2024 · MD · contact PI
Investigator Development Core$589,156
P50 · FY2023 · MD · contact PI
Investigator Development Core$593,300
P50 · FY2022 · MD · contact PI
Investigator Development Core$604,641
P50 · FY2021 · MD · contact PI
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study$141,596
R21 · FY2010 · DA · contact PI
Tanzanian Drug Treatment as AIDS Prevention - Reliability and Validity Study$203,117
R21 · FY2009 · DA · contact PI
Positive Choices Research Project$502,983
R01 · FY2007 · DA · contact PI
Positive Choices Research Project$505,821
R01 · FY2006 · DA · contact PI
Tanzania Injection Drug Use/HIV Prevention Project$181,995
R21 · FY2006 · DA · contact PI
A Test of Peer Delivered Self-Efficacy Intervention$675,719
R01 · FY2005 · DA
Positive Choices Research Project$504,321
R01 · FY2005 · DA
Social Network of a Highly Active HIV/STD Core Group$430,832
R01 · FY2005 · DA
Tanzania Injection Drug Use/HIV Prevention Project$171,629
R21 · FY2005 · DA
EFFECT OF UREMIC GLUCOSE INTOLERANCE ON AGE'S &AGE LEVELS W/ VASCULAR DISEASE$1,365
M01 · FY2005 · RR
A Test of Peer Delivered Self-Efficacy Intervention$666,421
R01 · FY2004 · DA
Positive Choices Research Project$488,130
R01 · FY2004 · DA
Social Network of a Highly Active HIV/STD Core Group$437,606
R01 · FY2004 · DA
Uremic Advanced Glycosylation End-Product Accumulation and Vascular Disease$4,660
M01 · FY2004 · RR
A Test of Peer Delivered Self-Efficacy Intervention$784,034
R01 · FY2003 · DA
Positive Choices Research Project$494,853
R01 · FY2003 · DA
Social Network of a Highly Active HIV/STD Core Group$425,578
R01 · FY2003 · DA
A Test of Peer Delivered Self-Efficacy Intervention$655,665
R01 · FY2002 · DA
Social Network of a Highly Active HIV/STD Core Group$462,405
R01 · FY2002 · DA
A Test of Peer Delivered Self-Efficacy Intervention$112,763
R01 · FY2002 · DA
A Test of Peer Delivered Self-Efficacy Intervention$579,806
R01 · FY2001 · DA
INTERVENTION EFFICACY TARGETING MALE PROSTITUTES$503,777
R01 · FY2000 · DA
CONDOM USE AMONG DRUG USERS RECEIVING ANTIRETROVIRALS$84,130
R03 · FY2000 · DA